Dreamerv4.0.0

Scientists can use Dreamer to generate novel molecules that respond to specific visible light wavelengths for controlled drug release. The system integrates MoE/Dense LLMs for molecular generation and quantum/classical classifiers for property prediction, enabling rapid prototyping of smart materials.

Given a large pool of candidate molecules, Dreamer can calculate QED/SA scores, perform data cleaning, and recommend top candidates using graph-based ranking. This accelerates the selection process for drug delivery applications.

Researchers can leverage Dreamer's quantum classifiers (QSVM/QNN) alongside deep learning models to predict photoresponsive properties with higher accuracy. This demonstrates quantum advantage in molecular property prediction.

Dreamer can automatically scrape ArXiv and news articles to update its knowledge base, enabling it to incorporate the latest mechanisms into molecular design. Useful for staying ahead in competitive research fields.

Companies with private molecular datasets can use Dreamer's CPO/ORPO reinforcement learning fine-tuning to align generation with their specific preferences, ensuring IP isolation and tailored outputs.

Offer Dreamer as a cloud platform where users pay a monthly fee for access to molecular generation, classification, and recommendation tools. Includes regular updates and priority support.

Provide tailored molecular design projects for pharma companies, including full workflow execution, analysis reports, and IP-secured outputs. Billed per project with premium pricing.

License the entire Dreamer codebase and skill package to large R&D organizations for internal deployment. Includes installation support, training, and customization.